DeveloGen Israel, Ltd.
1 clinical trials · Sponsor
◉ Watch DeveloGen Israel, Ltd.
| Record | Firm | Date |
|---|---|---|
| Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA) (NCT00058981) | DeveloGen Israel, Ltd. | 2002-10-01 |
Track DeveloGen Israel, Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.